Status:
COMPLETED
The Effect of Salmeterol on Eosinophil (EOS) Function
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
GlaxoSmithKline
Conditions:
Allergic Asthma
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
This study is designed to test the hypothesis that salmeterol use, and not fluticasone use or the combination treatment with fluticasone and salmeterol, is associated with a greater number of sputum e...
Detailed Description
An antigen challenge is when a participant inhales either cat, ragweed, or dust dander in increasing concentrations until their lung function drops 15 or 20 percent.
Eligibility Criteria
Inclusion
- 18-55 years of age
- history of asthma symptoms for the previous 6 months
- Forced Expiratory Value (FEV1) \>75% of predicted
- positive prick skin test to cat, house dust mite or ragweed
Exclusion
- history of life threatening asthma or anaphylaxis
- current smoker
- pregnant or breast-feeding
- evidence of an upper respiratory infection within 4 weeks of screening
Key Trial Info
Start Date :
November 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00214019
Start Date
November 1 2003
End Date
January 1 2008
Last Update
November 21 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin
Madison, Wisconsin, United States, 53792